Last updated on June 2016

Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.


Brief description of study

The CHEOPS study aims to confirm the clinical benefit of a combination of an anti-aromatase and metronomic chemotherapy treatment

Detailed Study Description

The CHEOPS study aims to confirm the clinical benefit of a combination of an anti-aromatase and metronomic chemotherapy treatment that would have the theoretical advantage of being well tolerated and more effective than chemotherapy alone even after an anti-aromatase therapy.

Clinical Study Identifier: NCT02585388

Contact Investigators or Research Sites near you

Start Over

Michèle TORRES-MACQUE

CH Chartres H pital Louis Pasteur
Le Coudray, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.